Ipca Laboratories Bilan de santé
Santé financière contrôle des critères 5/6
Ipca Laboratories possède un total de capitaux propres de ₹77.3B et une dette totale de ₹14.4B, ce qui porte son ratio d'endettement à 18.6%. Son actif total et son passif total sont ₹111.0B et de ₹33.7B. L'EBIT de Ipca Laboratories est ₹9.9B ce qui fait que son ratio de couverture des intérêts 14.7. Elle dispose de liquidités et de placements à court terme de ₹8.5B.
Informations clés
18.6%
Ratio d'endettement
₹14.38b
Dette
| Ratio de couverture des intérêts | 14.7x |
| Argent liquide | ₹8.54b |
| Fonds propres | ₹77.27b |
| Total du passif | ₹33.74b |
| Total des actifs | ₹111.01b |
Mises à jour récentes de la santé financière
Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Jan 09
Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Aug 20Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet
Feb 28Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Sep 20Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Jun 22Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Mar 15Recent updates
Earnings Tell The Story For Ipca Laboratories Limited (NSE:IPCALAB)
Sep 10Ipca Laboratories' (NSE:IPCALAB) Solid Earnings Have Been Accounted For Conservatively
Jun 07Ipca Laboratories Limited (NSE:IPCALAB) Not Lagging Market On Growth Or Pricing
May 24Investors Interested In Ipca Laboratories Limited's (NSE:IPCALAB) Earnings
Feb 07Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Jan 09Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Aug 20Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet
Feb 28Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Sep 20Estimating The Intrinsic Value Of Ipca Laboratories Limited (NSE:IPCALAB)
Aug 31Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Jun 22Calculating The Fair Value Of Ipca Laboratories Limited (NSE:IPCALAB)
May 28Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Mar 15These 4 Measures Indicate That Ipca Laboratories (NSE:IPCALAB) Is Using Debt Reasonably Well
Sep 20Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?
Aug 09Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Jun 08How Does Ipca Laboratories Limited (NSE:IPCALAB) Stand Up To These Simple Dividend Safety Checks?
Mar 26Do Ipca Laboratories's (NSE:IPCALAB) Earnings Warrant Your Attention?
Mar 13Trade Alert: The Compliance Officer Of Ipca Laboratories Limited (NSE:IPCALAB), Harish Kamath, Has Sold Some Shares Recently
Feb 28Ipca Laboratories Limited's (NSE:IPCALAB) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 23Does Ipca Laboratories' (NSE:IPCALAB) CEO Salary Compare Well With Industry Peers?
Feb 11Could The Ipca Laboratories Limited (NSE:IPCALAB) Ownership Structure Tell Us Something Useful?
Jan 30The Ipca Laboratories (NSE:IPCALAB) Share Price Is Up 264% And Shareholders Are Boasting About It
Jan 15Ipca Laboratories (NSE:IPCALAB) Seems To Use Debt Rather Sparingly
Dec 31
Don't Ignore The Fact That This Insider Just Sold Some Shares In Ipca Laboratories Limited (NSE:IPCALAB)
Dec 16Analyse de la situation financière
Passif à court terme: Les actifs à court terme de IPCALAB ( ₹55.4B ) dépassent ses passifs à court terme ( ₹23.6B ).
Passif à long terme: Les actifs à court terme de IPCALAB ( ₹55.4B ) dépassent ses passifs à long terme ( ₹10.2B ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de IPCALAB ( 7.6% ) est considéré comme satisfaisant.
Réduire la dette: Le ratio d'endettement de IPCALAB est passé de 14.8% à 18.6% au cours des 5 dernières années.
Couverture de la dette: La dette de IPCALAB est bien couverte par le flux de trésorerie opérationnel ( 65.7% ).
Couverture des intérêts: Les paiements d'intérêts de IPCALAB sur sa dette sont bien couverts par l'EBIT ( 14.7 x couverture).